Alpha lipoic acid market to accrue substantial revenue via dietary supplements applications over 2017-2024, APAC to majorly impact the regional growth
The growth of alpha lipoic acid market can be mainly attributed to the product’s application as a remedial agent in a plethora of chronic ailments. As per the NCBI, ALA has proved to be effective for reducing oxidative stress, protecting against atherosclerosis, and improving endothelial dysfunction, on the grounds of which this compound may be used as a therapeutic agent for diabetes, cancer, Alzheimer’s, obesity, cardiovascular diseases, osteoporosis, high blood pressure, non-alcoholic fatty liver disorder, Down syndrome, glaucoma, and burning mouth syndrome. The use of alpha lipoic acid, a naturally occurring thiol antioxidant, in anti-oxidant medicine treatment for various diseases is expected to create lucrative growth avenues for alpha lipoic acid industry players. Global Market Insights, Inc., reports that alpha lipoic acid industry size is likely to surpass a revenue of over USD 19 million by 2024, recording a CAGR of more than 6% over 2017-2024.
U.S. alpha lipoic acid market size, by product, 2013 – 2024 (USD Thousand)
In 1959, Germany became the first country to demonstrate the medical use of ALA for treating diabetic sensorimotor polyneuropathy due to amanita phalloides, which is a kind of mushroom abundantly found across Europe. Researchers have stated that the product, in its compact form – dihydrolipoic acid, can function as a metal chelator and biological antioxidant, helping to reduce the oxidized forms of glutathione, vitamin C, and vitamin E. Moreover, the product can also act upon signaling transduction of pathways such as adenosine monophosfatase protein kinase, insulin pathway, and nuclear factor kappa B. Alpha lipoic acid industry is expected to experience heavy capital investments from existing industry players as well as new entrants due to huge growth opportunities offered by this fraternity, subject to its widespread scope of applications.
Get a Sample Copy of this Report@ https://www.gminsights.com/request-sample/detail/1605
The conclusions drawn from several experimental studies have proved that ALA can inhibit the growth of atherosclerosis plaque as well as atherosclerosis and can lower oxidative stress occurring post heavy training activities. Today, ALA (Alpha Lipoic Acid) finds growing usage as a food supplement across the medical and nutritional management sectors. Rising popularity of ALA usage across myriad sectors will spur alpha lipoic acid market expansion over 2017-2024.
Despite providing benefits, ALA usage has also led to the demonstration of side effects such as skin allergies and gastrointestinal distress issues such as abdominal pain, nausea, dyspepsia, and vomiting in patients who were injected with the prescribed doses of alpha lipoic acid. Results derived from the trials conducted on the patients after administering ALA have depicted the occurrence of skin ulcers, pruritus, hypoglycemia, and bronchitis in patients. As per a recent study, patients injected with ALA suffered from insulin autoimmune syndrome, which is related to the application of the product as a dietary supplement. Side-effects witnessed in the patients after the product consumption can adversely impact the development of alpha lipoic acid industry. However, research is being conducted at an international level to find out alternatives that may counter the side-effects of ALA usage.
Speaking in terms of geographical trends, alpha lipoic acid industry is set to expand its footprints across major regions – North America, Latin America, and the Asia Pacific. As per estimates, Latin America alpha lipoic acid market is slated to grow at a rate of 6% over the coming timeline. The growth graph of this business space across this region may depict an upward trend subject to the substantial government funding to improve the healthcare facilities. Brazil is forecast to be a key regional growth driver. In North America though, alpha lipoic acid market share will be considerably augmented by the emerging pharmaceutical sector and the escalating need for dietary supplements & slimming products.
The thriving medical sector across the Asia Pacific is certain to be one of key factors driving the growth of alpha lipoic acid industry across this continent. With China and India striving to enhance their healthcare infrastructure, APAC alpha lipoic acid market will carve a profitable growth curve ahead, having held a valuation of USD 3.5 million in 2016.
Despite being one of many dubious markets in the chemical sector, the competitive landscape of alpha lipoic acid industry encompasses quite a few renowned participants, namely, Sabinsa Corporation, AlzChem AG, HiMedia Laboratories, Shanghai Shyndec Pharmaceutical Company Limited, and Health Genesis Corporation. The aforementioned biggies are expected to bet big on this business in the future, according to analysts. These ALA market participants are also predicted to improve their brand presence through product portfolio expansion, joint ventures, and strategic collaborations.
Author Name : Dhananjay Punekar